secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2026-10-07T12:01:12+00:00
Accession:  0001628280-26-065292
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.05, 2.06, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Azenta restructures Multiomics: closing 3 North American lab sites, $11-13M charges, $11M annual savings
--------------------------------------------------------------------------------

- Board approved the plan on October 5, 2026 to consolidate the North American lab network; employee notifications began October 6, 2026.
- Closing three Multiomics laboratory sites in North America plus workforce reductions; actions expected substantially complete by March 31, 2027.
- Estimated pre-tax charges of $11.0M-$13.0M: ~$9.0M impairment plus ~$3.0M severance/other; future cash expenditures ~$7.0M.
- Approximately $9.0M impairment covers operating lease right-of-use assets and leasehold improvements at leased facilities Azenta expects to exit before lease expiry.
- Expects ~$11.0M annualized cost savings once fully implemented; charges mostly recognized in fiscal year ending September 30, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000162828026065292/0001628280-26-065292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000162828026065292/azta-20261005.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-065292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer